EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of Sphingolipids and Sphingosine-1-phosphate—Sphingosine-1-phosphate-receptor Signaling in Psoriasis

Kana Masuda-Kuroki iD, Shahrzad Alimohammadi iD, Anna Di Nardo iD

Cells · 2023

DOI: 10.3390/cells12192352 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2023. Verfasst von Kana Masuda-Kuroki und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, School of Medicine, University of California San Diego, La Jolla, CA 92093, USA. Hauptthemen laut MEDLINE: Sphingolipids, Psoriasis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, NIH National Institute of Allergy and Infectious Diseases (NIAID).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psoriasis is a long-lasting skin condition characterized by redness and thick silver scales on the skin’s surface. It involves various skin cells, including keratinocytes, dendritic cells, T lymphocytes, and neutrophils. The treatments for psoriasis range from topical to systemic therapies, but they only alleviate the symptoms and do not provide a fundamental cure. Moreover, systemic treatments have the disadvantage of suppressing the entire body’s immune system. Therefore, a new treatment strategy with minimal impact on the immune system is required. Recent studies have shown that sphingolipid metabolites, particularly ceramide and sphingosine-1-phosphate (S1P), play a significant role in psoriasis. Specific S1P–S1P-receptor (S1PR) signaling pathways have been identified as crucial to psoriasis inflammation. Based on these findings, S1PR modulators have been investigated and have been found to improve psoriasis inflammation. This review will discuss the metabolic pathways of sphingolipids, the individual functions of these metabolites, and their potential as a new therapeutic approach to psoriasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SphingolipidsPsoriasisHumansSphingosine-1-Phosphate ReceptorsInflammationLysophospholipidsSphingosine

Stichwörter der Autor:innen

ceramidepsoriasissphingolipidsphingosine-1-phosphatesphingosine-1-phosphate receptor

Substanzen

SphingolipidsSphingosine-1-Phosphate Receptorssphingosine 1-phosphateLysophospholipidsSphingosine

Autor:innen und Institutionen

  • Department of Dermatology, School of Medicine, University of California San Diego, La Jolla, CA 92093, USA.

ORCID-Profile: Kana Masuda-Kuroki, Shahrzad Alimohammadi, Anna Di Nardo

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • NIH National Institute of Allergy and Infectious Diseases (NIAID)

Zitieren

APA

Masuda-Kuroki, K., Alimohammadi, S., & Di Nardo, A. (2023). The Role of Sphingolipids and Sphingosine-1-phosphate—Sphingosine-1-phosphate-receptor Signaling in Psoriasis. Cells. https://doi.org/10.3390/cells12192352

Vancouver

Masuda-Kuroki K, Alimohammadi S, Di Nardo A. The Role of Sphingolipids and Sphingosine-1-phosphate—Sphingosine-1-phosphate-receptor Signaling in Psoriasis. Cells. 2023. doi:10.3390/cells12192352

BibTeX
@article{MasudaKuroki2023,
  author = {Masuda-Kuroki, Kana and Alimohammadi, Shahrzad and Di Nardo, Anna},
  title = {The Role of Sphingolipids and Sphingosine-1-phosphate—Sphingosine-1-phosphate-receptor Signaling in Psoriasis},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12192352}
}
Kostenlos starten →